V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190007302 | 190004402 | 1.6 | 92 | Curative (C) | 2018-05-26 | 2018-05-26 | TOPOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 100186441 |
| 190007305 | 190004403 | null | 89.7 | Curative (C) | 2017-06-06 | 2017-06-21 | OST Mifamurtide | 02 | N | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + PACLITAXEL | 101313170 |
| 190007306 | 190004404 | 1.45 | 34.9 | null | 2020-07-30 | 2020-07-30 | GemCarbo Days 1+8 | 01 | N | GEMCITABINE | 100791055 |
| 190007307 | 190004405 | 1.81 | 87.2 | null | 2017-01-30 | 2017-02-03 | Cisplatin | 02 | N | CISPLATIN | 101234427 |
| 190007313 | 190004406 | 1.68 | 65.4 | Palliative (P) | 2019-08-03 | 2019-09-19 | OST Euramos 1 Closed Trial - Ai | 2 | N | CISPLATIN + ETOPOSIDE | 100439831 |
| 190007316 | 190004407 | 1.61 | 73.2 | Curative (C) | 2016-02-23 | 2016-02-29 | Doxorubicin + Methotrexate | 02 | N | PACLITAXEL | 101689626 |
| 190007323 | 190004408 | 0 | 38.9 | Curative (C) | 2021-08-16 | 2021-08-16 | MAP | 02 | N | LIPOSOMAL DOXORUBICIN | 100050738 |
| 190007324 | 190004409 | 0 | 15.5 | Palliative (P) | 2019-08-03 | 2020-10-25 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | CISPLATIN | 100323655 |
| 190007331 | 190004410 | 1.85 | 76.3 | null | 2016-11-01 | 2016-11-04 | Capecitabine | 02 | N | NIVOLUMAB | 100832363 |
| 190007335 | 190004411 | 1.57 | 78 | Curative (C) | null | 2018-07-22 | EURAMOS TRIAL | N | N | PACLITAXEL | 100190628 |
| 190007342 | 190004412 | null | 76.3 | Neo-adjuvant (N) | 2019-04-01 | 2019-04-29 | EW EuroEwing 2012 Arm A VAI | 02 | Y | DOCETAXEL | 100474435 |
| 190007367 | 190004413 | 1.63 | 100 | Palliative (P) | null | 2016-08-07 | PACLITAXEL | 02 | null | CARBOPLATIN + ETOPOSIDE | 100130976 |
| 190007369 | 190004414 | 1.66 | 82.5 | Adjuvant (A) | 2018-10-03 | 2018-10-30 | EW EuroEwing 2012 Arm A VAI | null | null | LANREOTIDE | 100127421 |
| 190007377 | 190004415 | 1.83 | 68 | Curative (C) | 2017-12-02 | 2018-04-20 | Capecitabine + Streptozocin | 01 | N | TRIAL UNSPECIFIED | 101502456 |
| 190007378 | 190004416 | 1.81 | 26.3 | null | 2019-01-21 | 2019-02-11 | CISPLATIN + RT | 02 | null | CISPLATIN | 101258138 |
| 190007383 | 190004417 | 1.49 | 34.1 | Palliative (P) | 2017-02-10 | 2017-02-10 | Paclitaxel 7 day | 02 | N | OCTREOTIDE | 100059284 |
| 190007387 | 190004418 | 1.72 | 67.3 | Disease modification (D) | 2019-07-28 | 2019-08-16 | EW EuroEwing 2012 Arm A VAI | 02 | N | CAPECITABINE + IRINOTECAN | 100051375 |
| 190007390 | 190004419 | 1.79 | 88.4 | Curative (C) | 2018-12-20 | 2019-05-22 | OST Euramos 1 Closed Trial - M | 02 | null | ATEZOLIZUMAB | 100121193 |
| 190007391 | 190004420 | null | 67 | Neo-adjuvant (N) | null | 2018-06-17 | POMB/ACE | null | null | MELPHALAN | 101381997 |
| 190007398 | 190004421 | 1.59 | 41.3 | Curative (C) | 2015-08-24 | 2016-07-29 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100642019 |
| 190007402 | 190004422 | 1.14 | 78.9 | Curative (C) | 2016-08-01 | 2016-08-09 | CARBOPLATIN + RT | 02 | N | CARBOPLATIN | 100907940 |
| 190007410 | 190004423 | 1.66 | 85 | null | 2017-11-22 | 2017-12-06 | OST Euramos 1 Closed Trial - AP | 02 | Y | CISPLATIN + ETOPOSIDE | 101493102 |
| 190007411 | 190004424 | 0 | 45.3 | null | 2020-11-09 | 2020-11-30 | EW EuroEwing 2012 Arm A VAI | 02 | N | GEMCITABINE | 100663253 |
| 190007429 | 190004425 | 1.73 | null | Neo-adjuvant (N) | 2016-09-08 | 2016-09-08 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE | 101061738 |
| 190007432 | 190004426 | 1.74 | 82 | null | 2018-08-18 | 2019-03-02 | EVEROLIMUS | 02 | N | FLUOROURACIL + OXALIPLATIN | 100260146 |
| 190007433 | 190004427 | 1.73 | 55.4 | Curative (C) | 2019-12-26 | 2020-01-02 | Avelumab | 2 | null | CNS ATRT CARBOPLATIN/THIOTEPA + GCSF | 100337818 |
| 190007436 | 190004428 | 1.76 | 92.5 | Adjuvant (A) | 2018-05-02 | 2018-08-23 | OST Euramos 1 Closed Trial - M | 02 | N | RMS 2005 TRIAL | 100867657 |
| 190007438 | 190004429 | 1.57 | 57.3 | Palliative (P) | 2019-03-12 | 2019-03-17 | CARBOPLATIN + PACLITAXEL | 02 | Y | CARBOPLATIN + PACLITAXEL | 101038664 |
| 190007440 | 190004430 | 1.71 | 69.3 | Neo-adjuvant (N) | 2016-05-08 | 2016-06-04 | Capecitabine + Cisplatin | 02 | null | EW EUROEWING 2012 ARM A VAI | 101535088 |
| 190007441 | 190004431 | 1.5 | 0 | null | null | 2019-11-04 | GEMCARBO | null | null | PACLITAXEL | 100399374 |
| 190007442 | 190004432 | null | 58.7 | Curative (C) | 2019-03-15 | 2019-04-01 | Carboplatin + Docetaxel | N | N | GEMCITABINE + NAB-PACLITAXEL | 100178313 |
| 190007446 | 190004433 | 1.6 | 72 | null | 2018-10-25 | 2018-10-25 | Irinotecan + Modified De Gramont | 02 | Y | GEMCARBO | 101122694 |
| 190007452 | 190004434 | 1.63 | null | null | 2013-05-11 | 2013-05-15 | DHAP | 02 | N | CARBOPLATIN + GEMCITABINE | 101061886 |
| 190007453 | 190004435 | 0 | 42.7 | Neo-adjuvant (N) | 2016-12-09 | 2016-12-10 | Capecitabine + Oxaliplatin 14day | N | null | DOCETAXEL | 100432894 |
| 190007455 | 190004436 | 1.69 | 89.8 | null | 2016-08-12 | 2016-08-12 | Folfirinox | 02 | N | ETOPOSIDE | 101316682 |
| 190007457 | 190004437 | 1.84 | null | null | 2016-06-14 | 2016-06-19 | Capecitabine | 01 | N | RMS 2005 TRIAL | 101264600 |
| 190007458 | 190004438 | 1.81 | 40 | Curative (C) | 2018-12-02 | 2018-12-22 | Carboplatin + Docetaxel | 99 | null | GEMCITABINE | 101252597 |
| 190007459 | 190004439 | 1.82 | 63.2 | Curative (C) | 2017-11-10 | 2018-05-14 | EURO-EWING | 02 | N | CARBOPLATIN + FLUOROURACIL | 101279490 |
| 190007464 | 190004440 | 0 | 37.4 | Palliative (P) | 2017-09-06 | 2017-09-20 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 100312793 |
| 190007469 | 190004441 | 1.59 | 25.1 | Palliative (P) | 2019-12-15 | 2019-12-15 | CAPECITABINE + CARBOPLATIN | 02 | null | PACLITAXEL | 101202023 |
| 190007473 | 190004443 | 1.76 | 53.3 | Palliative (P) | null | 2021-12-15 | VINCRISTINE | null | null | CAPECITABINE + CARBOPLATIN | 101733467 |
| 190007480 | 190004444 | 1.78 | 84.7 | Curative (C) | 2018-08-22 | 2018-08-22 | EW Rel rEECur Topotecan/Cyclophosphamide | 1 | N | CISPLATIN | 101437620 |
| 190007488 | 190004445 | 1.57 | 78.5 | null | 2016-09-03 | 2016-09-13 | Cisplatin +Fluorouracil (3 wk) | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 101416184 |
| 190007490 | 190004446 | 1.77 | 96 | Neo-adjuvant (N) | 2016-12-22 | 2016-12-28 | null | 02 | N | NIVOLUMAB | 101074391 |
| 190007492 | 190004447 | 1.55 | 48.4 | Palliative (P) | 2017-08-11 | 2018-02-20 | EP | 01 | N | LIPOSOMAL DOXORUBICIN | 100006620 |
| 190007497 | 190004448 | 1.8 | 76.3 | null | 2018-07-22 | 2018-07-29 | VAI (Ifos 3g/m2) | N | N | CISPLATIN + GEMCITABINE | 101185860 |
| 190007499 | 190004449 | 1.61 | 71.6 | null | 2018-10-27 | 2018-11-07 | CISPLATIN + GEMCITABINE | 02 | N | CAPECITABINE + IRINOTECAN | 101176230 |
| 190007503 | 190004450 | 1.6 | 83.2 | Adjuvant (A) | null | 2018-01-05 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101464057 |
| 190007504 | 190004451 | 1.76 | 67.8 | Curative (C) | 2019-05-23 | 2019-11-08 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100360125 |
| 190007515 | 190004452 | 1.51 | 57 | Adjuvant (A) | 2016-06-01 | 2017-02-02 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | CAPECITABINE + STREPTOZOCIN | 100686918 |